A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

NCT07003542 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Brain Tumor

Interventions

DRUG: Sitagliptin

Sponsor

Case Comprehensive Cancer Center